Report ID
|
11253 |
Drug Identification Number
|
02212188 |
Brand name
|
IMITREX INJECTION 12MG/ML |
Common or Proper name
|
Sumatriptan succinate injection |
Company Name
|
GLAXOSMITHKLINE INC |
Market Status
|
MARKETED |
Active Ingredient(s)
|
SUMATRIPTAN |
Strength(s)
|
12MG |
Dosage form(s)
|
LIQUID |
Route of administration
|
SUBCUTANEOUS |
Packaging size
|
2x0.5mL (Refill pack/L’emballage de recharge) |
ATC code
|
N02CC |
ATC description
|
ANTIMIGRAINE PREPARATIONS |
Reason for shortage
|
Shortage of an active ingredient. |
Anticipated start date
|
|
Actual start date
|
2017-06-29 |
Estimated end date
|
2018-02-28 |
Actual end date
|
2018-02-07 |
Shortage status
|
Resolved |
Updated date
|
2018-02-08 |
Company comments
|
|
Health Canada comments
|
|
Tier 3 Status
|
No |
Company contact information |
1-800-387-7374 |